LEAH Labs is bringing regenerative immunotherapy to dogs. We use gene editing to enable the translation of cell therapies from successful application in humans into the canine market. We aim to treat spontaneous, naturally occurring disease in dogs as a clear unmet business need, while also using dogs as a model to better inform human therapeutic intervention.